特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
962917

世界の細胞株開発市場規模調査:製品別、タイプ別、用途別、地域別予測(2020年~2027年)

Global Cell Line Development Market Size study, by Product, Type by Application and Regional Forecasts 2020-2027

出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.45円
世界の細胞株開発市場規模調査:製品別、タイプ別、用途別、地域別予測(2020年~2027年)
出版日: 2020年10月01日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞株開発の市場規模は、2019年におよそ42億1,000万米ドルとなりました。同市場は、2020~2027年の予測期間にかけて、13.40%を超える健全な成長率で拡大すると予測されています。

細胞株は、細胞が適切な増殖培地および空間で増殖する確立された細胞培養物です。細胞株は、細胞の生理学、構造、および遺伝子構成に段階的な変化をもたらします。細胞株の開発には、高レベルで一貫した標的治療タンパク質を産生する単一細胞由来のクローンの発見が必要です。

細胞株は、薬物および毒性化合物の細胞に対する影響、細胞の生化学および生理学、薬物のスクリーニングおよび開発、ならびに生物学的化合物の大規模製造の研究で使用される主要なツールの1つです。その用途には、研究、バイオプロダクション、診断が含まれ、市場の成長を促進しています。

また、モノクローナル抗体の需要の高まりとブロックバスターの生物製剤の特許満了が、予測期間にわたって細胞株開発業界を牽引すると予想されます。さらに、自己免疫疾患と癌の有病率が上昇していることで、正確で費用効果の高い治療オプションの需要を高める可能性があり、これが市場の成長にプラスの影響を与えています。

さらに、ワクチン生産の増加とバイオシミラーの需要の増加が市場の成長を促進しています。 2020年9月、Slentimは幹細胞の単一細胞クローニングのための新しいワークフローを開始しました。 SolentiumのVIPS機器と新しいMatriClone Matrixの組み合わせにより、クローニングの効率が4~5倍向上することを示しています。

同月、Octapharmaは、ゲノミクスベースの細胞株開発と細胞培養最適化ワークフローを合理化するための中央計算プラットフォームとしてGenedata's Selectorを選択したことを発表しました。ただし、高い資本コストは2020年から2027年の予測期間にわたって市場の成長を妨げるとみられています。とはいえ、研究開発への多額の投資は、市場に豊富な機会をもたらします。

当レポートでは、世界の細胞株開発市場について調査し、市場の概要とともに、製品別、タイプ別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の細胞株開発市場の定義と範囲

第3章 世界の細胞株開発市場力学

  • 細胞株開発市場の影響分析(2018年~2027年)

第4章 世界の細胞株開発市場産業分析

  • ポーターの5フォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論

第5章 世界の細胞株開発市場、製品別

  • 市場スナップショット
  • 世界の細胞株開発市場、パフォーマンス-潜在的な分析:製品別
  • 世界の細胞株開発市場の見積と予測:2017-2027年(10億米ドル):製品別
  • 細胞株開発市場、サブセグメント分析
    • 装置
    • 培地
    • 試薬

第6章 世界の細胞株開発市場、タイプ別

  • 市場スナップショット
  • 世界の細胞株開発市場、パフォーマンス-潜在的な分析:タイプ別
  • 世界の細胞株開発市場の見積と予測:2017-2027年(10億米ドル):タイプ別
  • 細胞株開発市場、サブセグメント分析
    • 一次細胞株
    • 連続細胞株
    • ハイブリドーマ
    • 組換え細胞株

第7章 世界の細胞株開発市場、用途別

  • 市場スナップショット
  • 世界の細胞株開発市場、パフォーマンス-潜在的な分析:用途別
  • 世界の細胞株開発市場の見積と予測:2017-2027年(10億米ドル):用途別
  • 細胞株開発市場、サブセグメント分析
    • バイオプロダクション
    • 組織工学および再生医療
    • 毒性試験
    • 調査
    • 創薬

第8章 世界の細胞株開発市場、地域分析

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他
  • アジア太平洋地域のスナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他
  • 中南米スナップショット
    • ブラジル
    • メキシコ
  • その他

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • American Type Culture Collection (ATCC)
    • Lonza Group AG
    • Thermo Fisher Scientific Inc
    • GE Healthcare
    • Sigma-Aldrich Corporation
    • Selexis SA
    • European Collection of Cell Cultures (ECACC)
    • Corning, Inc
    • WuXi AppTec, Inc
    • Sartorious AG

第10章 調査プロセス

図表

LIST OF TABLES

  • TABLE 1. Global Cell Line Development market, report scope
  • TABLE 2. Global Cell Line Development market estimates & forecasts by Region 2017-2027 (USD Billion)
  • TABLE 3. Global Cell Line Development market estimates & forecasts by Product 2017-2027 (USD Billion)
  • TABLE 4. Global Cell Line Development market estimates & forecasts by Type 2017-2027 (USD Billion)
  • TABLE 5. Global Cell Line Development market estimates & forecasts by Application 2017-2027 (USD Billion)
  • TABLE 6. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 7. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 8. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 9. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 10. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 11. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 12. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 13. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 14. Global Cell Line Development market by segment, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 15. Global Cell Line Development market by region, estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 16. U.S. Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 17. U.S. Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 18. U.S. Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 19. Canada Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 20. Canada Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 21. Canada Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 22. UK Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 23. UK Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 24. UK Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 25. Germany Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 26. Germany Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 27. Germany Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 28. RoE Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 29. RoE Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 30. RoE Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 31. China Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 32. China Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 33. China Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 34. India Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 35. India Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 36. India Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 37. Japan Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 38. Japan Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 39. Japan Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 40. RoAPAC Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 41. RoAPAC Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 42. RoAPAC Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 43. Brazil Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 44. Brazil Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 45. Brazil Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 46. Mexico Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 47. Mexico Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 48. Mexico Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 49. RoLA Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 50. RoLA Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 51. RoLA Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 52. Row Cell Line Development market estimates & forecasts, 2017-2027 (USD Billion)
  • TABLE 53. Row Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 54. Row Cell Line Development market estimates & forecasts by segment 2017-2027 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of global Cell Line Development market
  • TABLE 56. List of primary sources, used in the study of global Cell Line Development market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Cell Line Development market, research methodology
  • FIG 2. Global Cell Line Development market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Cell Line Development market, key trends 2019
  • FIG 5. Global Cell Line Development market, growth prospects 2020-2027
  • FIG 6. Global Cell Line Development market, porters 5 force model
  • FIG 7. Global Cell Line Development market, pest analysis
  • FIG 8. Global Cell Line Development market, value chain analysis
  • FIG 9. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
  • FIG 10. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
  • FIG 11. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
  • FIG 12. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
  • FIG 13. Global Cell Line Development market by segment, 2017 & 2027 (USD Billion)
  • FIG 14. Global Cell Line Development market, regional snapshot 2017 & 2027
  • FIG 15. North America Cell Line Development market 2017 & 2027 (USD Billion)
  • FIG 16. Europe Cell Line Development market 2017 & 2027 (USD Billion)
  • FIG 17. Asia pacific Cell Line Development market 2017 & 2027 (USD Billion)
  • FIG 18. Latin America Cell Line Development market 2017 & 2027 (USD Billion)
  • FIG 19. Global Cell Line Development market, company market share analysis (2019)
目次

Title:
Global Cell Line Development Market Size study, by Product (Equipment, Media, Reagents), Type (Primary Cell Lines, Continuous Cell Lines, Hybridomas, Recombinant Cell Lines) by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) and Regional Forecasts 2020-2027.

Global Cell Line Development Market is valued approximately USD 4.21 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 13.40 % over the forecast period 2020-2027. The cell line is an established cell culture where the cell multiply in apt growth medium and space. The cell lines provide stepwise alternations in the physiology, structure and genetic makeup of the cells. Cell line development requires the discovery of single cell-derived clones that produce high and consistent levels of the target therapeutic protein. Cell lines are one of the chief tools used in research for studying the effects of drugs and toxic compounds on the cells , the biochemistry and normal physiology of cells, drug screening and development and large scale manufacturing of biological compounds. The application for cell lines includes research, bioproduction and diagnostics drives the market growth. Also, increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period. Further, increasing prevalence of autoimmune diseases and cancer is likely to increase the demand for accurate and cost-effective treatment options which is expected to render a positive impact on market growth. Moreover, rising vaccine production and growing demand for biosimilars foster the market growth. As in September 2020, Slentim launched a new workflow for single cell cloning of stem cells. The combination of Solentium's VIPS instrument and new MatriClone Matrix demonstrates a 4 to 5- fold improvement in cloingcloning efficiency. While in the Same month, Octapharma announced to have selected Genedata's Selector as its Central computational platform to streamline genomics- based cell line development and cell culture optimization workflow. However, High capital cost impedes the growth of the market over the forecast period of 2020-2027. Although, high investments in R&D presents a lucrative opportunity for the market.

The regional analysis of global Cell Line Development market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the large base of biopharmaceutical companies and research and academic institutes in the region along with swelling research programs. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as rapidly improving health care facilities would create lucrative growth prospects for the Cell Line Development market across Asia-Pacific region.

Major market player included in this report are:

American Type Culture Collection (ATCC)

Lonza Group AG

Thermo Fisher Scientific Inc

GE Healthcare

Sigma-Aldrich Corporation

Selexis SA

European Collection of Cell Cultures (ECACC)

Corning, Inc

WuXi AppTec, Inc

Sartorious AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:

Equipment

Media

Reagents

By Type:

Primary Cell Lines

Continuous Cell Lines

Hybridomas

Recombinant Cell Lines

By Application:

Bioproduction

Tissue Engineering & Regenerative medicine

Toxicity Testing

Research

Drug Discovery

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Cell Line Development Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    • 1.2.1. Cell Line Development Market, by Region, 2018-2027 (USD Billion)
    • 1.2.2. Cell Line Development Market, by Product, 2018-2027 (USD Billion)
    • 1.2.3. Cell Line Development Market, by Type, 2018-2027 (USD Billion)
    • 1.2.4. Cell Line Development Market, by Application, 2018-2027 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cell Line Development Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cell Line Development Market Dynamics

  • 3.1. Cell Line Development Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Cell Line Development Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Cell Line Development Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Cell Line Development Market by Product, Performance - Potential Analysis
  • 5.3. Global Cell Line Development Market Estimates & Forecasts by Product 2017-2027 (USD Billion)
  • 5.4. Cell Line Development Market, Sub Segment Analysis
    • 5.4.1. Equipment
    • 5.4.2. Media
    • 5.4.3. Reagents

Chapter 6. Global Cell Line Development Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Cell Line Development Market by Type, Performance - Potential Analysis
  • 6.3. Global Cell Line Development Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
  • 6.4. Cell Line Development Market, Sub Segment Analysis
    • 6.4.1. Primary Cell Lines
    • 6.4.2. Continuous Cell Lines
    • 6.4.3. Hybridomas
    • 6.4.4. Recombinant Cell Lines

Chapter 7. Global Cell Line Development Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Cell Line Development Market by Application, Performance - Potential Analysis
  • 7.3. Global Cell Line Development Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
  • 7.4. Cell Line Development Market, Sub Segment Analysis
    • 7.4.1. Bioproduction
    • 7.4.2. Tissue Engineering & Regenerative medicine
    • 7.4.3. Toxicity Testing
    • 7.4.4. Research
    • 7.4.5. Drug Discovery

Chapter 8. Global Cell Line Development Market, Regional Analysis

  • 8.1. Cell Line Development Market, Regional Market Snapshot
  • 8.2. North America Cell Line Development Market
    • 8.2.1. U.S. Cell Line Development Market
      • 8.2.1.1. Product breakdown estimates & forecasts, 2017-2027
      • 8.2.1.2. Type breakdown estimates & forecasts, 2017-2027
      • 8.2.1.3. Application breakdown estimates & forecasts, 2017-2027
    • 8.2.2. Canada Cell Line Development Market
  • 8.3. Europe Cell Line Development Market Snapshot
    • 8.3.1. U.K. Cell Line Development Market
    • 8.3.2. Germany Cell Line Development Market
    • 8.3.3. France Cell Line Development Market
    • 8.3.4. Spain Cell Line Development Market
    • 8.3.5. Italy Cell Line Development Market
    • 8.3.6. Rest of Europe Cell Line Development Market
  • 8.4. Asia-Pacific Cell Line Development Market Snapshot
    • 8.4.1. China Cell Line Development Market
    • 8.4.2. India Cell Line Development Market
    • 8.4.3. Japan Cell Line Development Market
    • 8.4.4. Australia Cell Line Development Market
    • 8.4.5. South Korea Cell Line Development Market
    • 8.4.6. Rest of Asia Pacific Cell Line Development Market
  • 8.5. Latin America Cell Line Development Market Snapshot
    • 8.5.1. Brazil Cell Line Development Market
    • 8.5.2. Mexico Cell Line Development Market
  • 8.6. Rest of The World Cell Line Development Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. American Type Culture Collection (ATCC)
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Lonza Group AG
    • 9.2.3. Thermo Fisher Scientific Inc
    • 9.2.4. GE Healthcare
    • 9.2.5. Sigma-Aldrich Corporation
    • 9.2.6. Selexis SA
    • 9.2.7. European Collection of Cell Cultures (ECACC)
    • 9.2.8. Corning, Inc
    • 9.2.9. WuXi AppTec, Inc
    • 9.2.10. Sartorious AG

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.